Detalhe da pesquisa
1.
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Ann Hematol
; 102(2): 323-328, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576532
2.
Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial.
Oncologist
; 27(1): 67-78, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498352
3.
Cancer patients, physicians, and nurses differ in their attitudes toward the decisional role in do-not-resuscitate decision-making.
Support Care Cancer
; 28(12): 6057-6066, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32291599
4.
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Br J Haematol
; 190(3): e169-e173, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515072
5.
Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.
Clin Cancer Res
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874506
6.
Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol.
BMJ Open
; 13(1): e063500, 2023 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717150
7.
Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy.
Front Immunol
; 14: 1228907, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744345
8.
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).
Eur J Cancer
; 180: 125-133, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592507
9.
A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC).
Pharmaceutics
; 14(3)2022 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35335885
10.
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC).
J Clin Oncol
; 40(27): 3180-3189, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476508
11.
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096534
12.
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.
Curr Cancer Drug Targets
; 20(10): 811-817, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32598257